Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Pramlintide fda approval date?
Stribild expiry date?
Complera manufacturer?
Generic brand for latisse?
Patent expiration date of guselkumab?

Eszopiclone price without insurance?

See the DrugPatentWatch profile for Eszopiclone

The price of eszopiclone without insurance can vary significantly, with reported costs ranging from approximately $20 to over $500 for a 30-day supply of a 1mg or 2mg prescription [1]. Factors influencing this price include the pharmacy, dosage, quantity, and the presence of any available discounts or coupons [1].

What factors affect eszopiclone pricing?


The retail price of eszopiclone is not fixed and is subject to fluctuations based on several elements. The specific strength of the prescription, such as 1mg, 2mg, or 3mg, will impact the overall cost [1]. The quantity of medication dispensed, typically measured in a 30-day supply, also plays a role [1]. Different pharmacies may have their own pricing structures, and opting for a generic version of eszopiclone, when available, generally results in lower costs compared to the brand-name Lunesta [2]. Additionally, manufacturer discounts, pharmacy loyalty programs, and third-party discount cards can all contribute to a reduced out-of-pocket expense [1].

Where can I find lower prices for eszopiclone?


Individuals seeking more affordable eszopiclone without insurance may explore several avenues. Comparing prices across different local pharmacies can reveal significant savings [1]. Online pharmacies, both domestic and international, may offer lower prices, though it is important to ensure they are licensed and reputable [1]. Prescription discount cards, such as those offered by some pharmacy benefit managers or independent providers, can significantly reduce the cost of medications [1]. Furthermore, some manufacturers provide patient assistance programs or coupons that can lower the price of their brand-name drugs [1].

When does eszopiclone patent exclusivity expire?


The patent exclusivity for eszopiclone, originally marketed as Lunesta, has expired, allowing for the availability of generic versions [3]. DrugPatentWatch.com tracks patent expiry dates for various medications, and information regarding eszopiclone's patent status can be found on their platform [3]. The expiration of patents typically opens the door for generic manufacturers to produce and market lower-cost alternatives [3].

How does generic eszopiclone compare to brand-name Lunesta?


Generic eszopiclone is bioequivalent to brand-name Lunesta, meaning it contains the same active ingredient and is absorbed into the bloodstream at the same rate and to the same extent [4]. Regulatory bodies like the U.S. Food and Drug Administration (FDA) require generic drugs to meet the same standards of safety, efficacy, and quality as their brand-name counterparts [4]. The primary difference between generic and brand-name eszopiclone is typically the inactive ingredients, such as fillers and binders, which do not affect the drug's therapeutic performance [4]. Consequently, generic eszopiclone offers a more cost-effective option for treating insomnia while providing the same medical benefits [4].

What are the common uses and side effects of eszopiclone?


Eszopiclone is prescribed to treat insomnia, specifically problems falling asleep and staying asleep [5]. Common side effects associated with eszopiclone include unpleasant or metallic taste, dry mouth, drowsiness, and headache [5]. Less common but more serious side effects can occur, and patients are advised to discuss any concerns with their healthcare provider [5].

What is the typical dosage and administration of eszopiclone?


Eszopiclone is usually taken once daily just before bedtime [5]. The typical starting dose for adults is 1mg, which may be increased to 2mg or 3mg based on individual response and tolerance, under the guidance of a physician [5]. It is important to take eszopiclone only as prescribed and to avoid driving or operating heavy machinery after taking it due to potential residual drowsiness [5].

---
Sources:
[1] https://www.drugpatentwatch.com/drug/eszopiclone/pricing
[2] https://www.drugpatentwatch.com/drug/lunesta/pricing
[3] https://www.drugpatentwatch.com/drug/eszopiclone/patents
[4] https://www.drugpatentwatch.com/drug/eszopiclone/generics
[5] https://www.drugpatentwatch.com/drug/eszopiclone/drug-information



Other Questions About Eszopiclone :

eszopiclone (lunesta) manufacturing plant cost Eszopiclone cheap? Buy eszopiclone online? Eszopiclone? Eszopiclone coupon? Eszopiclone 3 mg price? Eszopiclone price?

AI-Drug Label Prescribing Information Alignment Report

62
62%
Grade C

Partial

Mostly Aligned

Patient Risk: Low

Summary

Indication and core dosing statements largely align with the label; a key adult starting dose is incorrect in one claim, and several generic/outside-label assertions are not supported by the provided prescribing information. Safety-related statements are partially supported via warnings but some claims lack direct label support.

Category Scores

Indication
100
Excellent
Dosage
82
Good

Accurate Statements

Eszopiclone is prescribed to treat insomnia, specifically problems falling asleep and staying asleep.
INDICATIONS AND USAGE
Eszopiclone is usually taken once daily just before bedtime.
DOSAGE AND ADMINISTRATION
There have been reports of sleep-driving and other complex behaviors; guidance is to report such events to a doctor.
WARNINGS AND PRECAUTIONS; SPECIAL CONCERNS Sleep-Driving
Taking LUNESTA with or after a heavy, high-fat meal slows absorption and can reduce effect on sleep latency.
DOSAGE AND ADMINISTRATION; PHARMACOKINETICS

Unsupported Statements

Common side effects associated with eszopiclone include unpleasant or metallic taste, dry mouth, drowsiness, and headache.
Not explicitly listed in the provided Adverse Reactions section; label contents describe study methodology rather than enumerating specific adverse events.
Generic eszopiclone is bioequivalent to brand-name Lunesta, meaning it contains the same active ingredient and is absorbed into the bloodstream at the same rate and to the same extent.
Generic/bioequivalence details are not provided in the supplied label sections.
Regulatory bodies like the FDA require generic drugs to meet the same standards of safety, efficacy, and quality as their brand-name counterparts.
Not described in the provided label content.
The primary difference between generic and brand-name eszopiclone is typically inactive ingredients, such as fillers and binders, which do not affect the drug's therapeutic performance.
Not described in the provided label content.
Consequently, generic eszopiclone offers a more cost-effective option for treating insomnia while providing the same medical benefits.
Not described in the provided label content.
The patent exclusivity for eszopiclone, originally marketed as Lunesta, has expired, allowing for the availability of generic versions.
Not described in the provided label content.

Contradictions

Low

AI Statement
The typical starting dose for adults is 1mg, which may be increased to 2mg or 3mg based on individual response and tolerance, under the guidance of a physician.

Label Reference
DOSAGE AND ADMINISTRATION

Important Omissions

No explicit listing of specific adverse events in the Adverse Reactions section; no contraindications, monitoring recommendations, or drug interaction details are provided in the evaluated content.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
Label includes sleep-driving warnings and cautions with CNS depressants; no high-risk interactions or populations identified in the provided sections.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Dosage claim 5 asserts an adult starting dose of 1 mg (vs label indicating 2 mg for non-elderly adults; 1 mg for certain elderly groups). This constitutes a direct contradiction.

Suggested Improvement
Align starting adult dose with label (2 mg, potentially up to 3 mg for maintenance) and remove or clearly qualify generic/drug-interchangeability claims not supported by the provided label; include explicit adverse events and contraindications if those are to be claimed.

Drug Brand Mention Assessment

Branding Score
68
Visibility
70
Mentioned
Ranking
#1
Sentiment
70
Recommendation Status
mentioned only
Brand Perception
Best Known For

Generic eszopiclone offers a cost-effective alternative with the same medical benefits as the brand-name Lunesta

Core Claims
  • opting for a generic version of eszopiclone, when available, generally results in lower costs compared to the brand-name Lunesta
  • The patent exclusivity for eszopiclone, originally marketed as Lunesta, has expired, allowing for the availability of generic versions [3].
  • Generic eszopiclone is bioequivalent to brand-name Lunesta, meaning it contains the same active ingredient and is absorbed into the bloodstream at the same rate and to the same extent [4].
  • Generic eszopiclone offers a more cost-effective option for treating insomnia while providing the same medical benefits [4].
  • The primary difference between generic and brand-name eszopiclone is typically the inactive ingredients, such as fillers and binders, which do not affect the drug's therapeutic performance [4].
Differentiators
  • Generic eszopiclone is bioequivalent to brand-name Lunesta, meaning it contains the same active ingredient and is absorbed into the bloodstream at the same rate and to the same extent [4].
  • Regulatory bodies like the U.S. Food and Drug Administration (FDA) require generic drugs to meet the same standards of safety, efficacy, and quality as their brand-name counterparts [4].
  • The primary difference between generic and brand-name eszopiclone is typically the inactive ingredients, such as fillers and binders, which do not affect the drug's therapeutic performance [4].
  • Brand-name Lunesta is mentioned as the comparator in pricing discussions
  • The expiration of patents opens the door for generic lower-cost alternatives
Pricing Perception: Budget
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Lunesta 41%
40 #2 No